Buradasınız

Anasayfa » Content

BAŞ-BOYUN KANSERLERİNDE TEDAVİ ÖNCESİ DENTAL GİRİŞİMLER:

Dental Assessment of Patients with Head-Neck Cancer Prior to Anticancer Therapy: Review of 35 Cases

Journal Name:

  • İstanbul Üniversitesi Diş Hekimliği Fakültesi Dergisi

Publication Year:

  • 2012

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Purpose: Head and neck cancer therapy including surgery, radiotherapy and chemotherapy may lead to acute and chronic complications of such as alterations in taste, oral mucositis, hyposalivation, radiation induced dental caries, trismus, delayed wound healing and osteoradionecrosis. The aim of our study is to compare the oral situation of patients, before and after treatment and emphasize the importance of the dental evaluation due to prevent and / or minimize of these complications. Material and Methods: In this study, the evaluation of 35 patients with primary head and neck tumors who had applied to our clinic between October 2006 and November 2007 for the oral health care consultation, dental treatments, and the 16,9-month follow-up results were reported. Results: All patients were treated periodontaly for dental arrangement of patients before oncology therapy. In addition, conservative restorations in a total of 28 teeth of 9 patients, fixed dentures in 9 patients, moving prosthetic applications in 13 patients were performed. Conclusion: Dental arrangements to do before oncology treatment, ongoing regular follow-up during and after treatment will minimize the problems of oral health after cancer treatment and increase quality of life.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Baş-boyun kanserlerinin tedavisinde uygulanan cerrahi, radyoterapi ve kemoterapi sonucunda tat almada bozukluk, mukozit, ağız kuruluğu, radyasyon çürükleri, trismus, yara iyileşmesinde gecikme ve osteoradyonekroz gibi yan etkiler oluşabilmektedir. Çalışmamızın amacı, bu yan etkilerin önlenmesi ve/veya en aza indirilmesi için hastaların, tedavi öncesi ve sonrası durumlarını karşılaştırmak ve dental değerlendirmenin önemini vurgulamaktır. Gereç ve Yöntem: Bu çalışmada Ekim 2006-Kasım 2007 tarihleri arasında kliniğimize ağız diş sağlığı konsültasyonu için başvuran 35 primer baş-boyun kanseri hastasının değerlendirilmesi, uygulanan tedaviler ve ortalama 16,9 aylık takiplerinin sonuçları bildirilmiştir. Bulgular: Hastaların onkoloji tedavisine dental olarak hazırlanmaları için tüm hastalara periodontal olarak başlangıç tedavisi yapılmıştır. Ayrıca 9 hastanın toplam 28 dişine konservatif restorasyonlar yapılırken, 9 hastaya sabit protez, 13 hastaya da hareketli protez uygulamaları yapılmıştır. Sonuç: Onkoloji tedavisine başlamadan önce yapılacak dental hazırlıklar, tedavi esnasında ve sonrasında devam edecek düzenli kontroller, hastaların tedavi sonrasındaki dönemde ağız ve diş sağlığı yönünden yaşayacakları problemleri en aza indirecek ve hayat kalitelerini arttıracaktır.
FULL TEXT (PDF): 
PDF icon arastirmax-bas-boyun-kanserlerinde-tedavi-oncesi-dental-girisimler.pdf
  • 2
1
12
  • Turkish

REFERENCES

References: 

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Froman D. Global cancer statistics. CA Cancer J Clin, 2011; 61: 69-90.
2.
A
snapshot of head and neck cancers National Institude of Health http://www.can- cer.gov/aboutnci/servingpeople/snapshots/ head-neck.pdf Erişim tarihi: 12 Aralık 2011.
3. Haydaroğlu A, Bölükbaşı Y, Özsaran Z. Ege Üniversitesinde kanser kayıt analizleri: 34134 olgunun değerlendirilmesi. Türk Onko Derg, 2007; 22: 22-28.
4. Danaei G, Hoorn SV,
Lope
z AD, Murray CJL, Ezzati M, and the Comparative Risk Assessment collaborating Group. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet, 2005; 366: 1784-93.
5.
Gondivka
r SM, Parikh RV, Gadbail AR Solanke V, Chole R, Mankar M, Balsaraf S. Involvement of viral factors with head and neck cancers. Oral Oncol, 2011 (baskıda).
6.
Moor
e SR, Johnson NW, Pierce AM, Wilson DF. The epidemiology of mouth cancer: a review of global incidence. Oral
Diseases, 2000; 6: 65-74.
7.
Hancoc
k PJ, Epstein JB, Sadler GR. Oral and dental management related to ra¬diation therapy for head and neck cancer. J Can Dent Assoc, 2003 ; 69(9): 585-90.
8.
Fanucch
i M, Khuri FR, Shin D, Johnstone PAS, Chen AM. Update in the management of head and neck cancer. Update Cancer Ther, 2006; 1: 211-19.
9.
Nabi
l S, Samman N. Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: a systematic review. Int J Oral Maxillofac Surg, 2011;
40(3): 229-43.
10. Chrcanovic BR, Reher P, Sousa AA, Harris M. Osteoradionecrosis of the jaws--a current overview-Part 2: dental management
11
K. Bektaş-Kayhan, M. Özdemir-Karataş, M. Ünür, Y. Keskin, M. Altun, Ö. Bayrak, O. Yazıcıoğlu
and therapeutic options for treatment. Oral Maxillofac Surg, 2010; 14(2): 81-95.
11. Agbaje JO, Jacobs R, Michiels K, Abu-Ta'a M, van Steenberghe D. Bone healing after dental extractions in irradiated patients: a pilot study on a novel technique for volume assessment of healing tooth sockets. Clin Oral Investig, 2009; 13(3): 257-61. Epub 2008 Nov 5.
12. Lizi EC. A case for a dental surgeon at regional radiotherapy centres. Br Dent J, 1992; 173(1): 24-26.
13. Bonan PR, Lopes MA, Pires FR, Almeida OP. Dental management of low socioeconomic level patients before radiotherapy of the head and neck with special emphasis on the prevention of osteoradionecrosis. Braz
Dent J, 2006; 17(4): 336-42.
14. Epstein JB, Parker IR, Epstein MS, Stevenson-Moore P. Cancer-related oral health care services and resources: a survey of oral and dental care in Canadian cancer centres. J Can Dent Assoc, 2004; 70(5): 302-04.
15. Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: a rando¬mized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc, 1985; 111(1): 49-54.
16. Sulaiman F, Huryn JM, Zlotolow IM. Dental extractions in the irradiated head and neck patient: a retrospective analysis of Memorial Sloan-Kettering Cancer Center protocols, criteria, and end results. J Oral Maxillofac Surg, 2003; 61(10): 1123-31.
17. Marx RE, Johnson RP. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol, 1987; 64(4): 379-90.
18. Thorn JJ, Hansen HS, Specht L, Bast-holt L. Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg, 2000; 58(10): 1088-93.
19. Porter SR, Fedele S, Habbab KM. Xerostomia in head and neck malignancy. Oral Oncol, 2010 ; 46(6): 460-63.
20. Rosales AC, Esteves SC, Jorge J, Almeida OP, Lopes MA. Dental needs in Brazilian patients subjected to head and neck
radiotherapy. Braz Dent J, 2009; 20(1): 74¬77.
21. Jham BC, Reis PM, Miranda EL, Lo¬pes RC, Carvalho AL, Scheper MA, Freire AR. Oral health status of 207 head and neck cancer patients before, during and after ra¬diotherapy. Clin Oral Investig, 2008; 12(1):
19-24.
22. Epstein JB, Emerton S, Lunn R, Le N, Wong FL. Pretreatment assessment and dental management of patients with nasop-haryngeal carcinoma. Oral Oncol, 1999; 35(1): 33-39.
23. Muwonge R, Ramadas K, Sankila R, Thara S, Thomas G, Vinoda J, Sanka-ranarayanan R. Role of tobacco smoking, chewing and alcohol drinking in the risk of oral cancer in Trivandrum, India: a nested case-control design using incident cancer
cases. Oral Oncol, 2008; 44(5): 446-54.
24. Pelucchi C, Tramacere I, Boffetta P, Negri E, La Vecchia C. Alcohol consumption and cancer risk. Nutr Cancer, 2011; 63(7):
983-90.
25. Szymahska K, Hung RJ, Wunsch-Filho V, Eluf-Neto J, Curado MP, Koifman S, Matos E, Menezes A, Fernandez L, Daudt AW, Boffetta P, Brennan P. Alcohol and to¬bacco, and the risk of cancers of the upper aerodigestive tract in Latin America: a case-control study. Cancer Causes Control, 2011;
22(7): 1037-46.
26. Znaor A, Brennan P, Gajalakshmi V, Mathew A, Shanta V, Varghese C, Boffetta P. Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal
ı2
Baş-Boyun Kanserlerinde Tedavi Öncesi Dental Girişimler: S5 Olgunun Değerlendirilmesi
cancers in Indian men. Int J Cancer, 2003; 105(5): 681-86.
27.
Zygogiann
i AG, Kyrgias G, Kara-kitsos P, Psyrri A, Kouvaris J, Kelekis N, Kouloulias V. Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol, 2011; 3: 2.
28.
Ekramuddaul
a FM, Siddique BH, Islam MR, Kabir MS, Alam MS. Evaluation of risk factors of oral cancer. Mymensingh Med J, 2011; 20(3): 412-18.
29.
Caribe-Gome
s F, Chimenos-Küstner E, Lopez-Lopez J, Finestres-Zubeldia F, Gu-ix-Melcior B. Dental management of the complications of radio and chemotherapy in oral cancer. Med Oral, 2003; 8(3): 178-87.
30. Gökalp S, Güçiz Doğan B, Tekçiçek M, Berberoğlu A, Ünlüer Ş. Erişkin ve Yaşlılarda Ağız-Diş Sağlığı Profili Türkiye-2004. Hacettepe Dişhekimliği Fakültesi Dergisi, 2007; 31(4): 11-18.
31. Tolentino Ede S,
Centurio
n BS, Ferreira LH, Souza AP, Damante JH, Rubira-Bullen IR. Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patients. J Appl Oral Sci, 2011; 19(5): 448-54.
32.
Kog
a DH, Salvajoli JV, Kowalski LP, Nishimoto IN, Alves FA. Dental extracti¬ons related to head and neck radiotherapy: ten-year experience of a single institution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008; 105(5): e1-6.
33.
Kog
a DH, Salvajoli JV, Alves FA. Dental extractions and radiotherapy in head and neck oncology: review of the literature. Oral Dis, 2008; 14(1): 40-44.
34. Feber T. Mouth care for patients re¬ceiving oral irradiation. Prof Nurse, 1995;
10(10): 666-70.
35.
Ston
e R, Fliedner MC, Smiet AC. Management of oral mucositis in patients
with cancer. Eur J Oncol Nurs, 2005; 9 Suppl 1: S24-32.
36. Okeson JP. Management of temporomandibular disorders and occlusion. St. Louis: Mosby; 1998.
37. Chen YY, Zhao C, Wang J, Ma HL, Lai SZ, Liu Y, Han F, Lu LX, Bao Y, Chen M. Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: a prospective study with >5 years of follow-up. Cancer. 2011; 117(13): 2910-16.

Thank you for copying data from http://www.arastirmax.com